Somatropin - Dong-A ST

Drug Profile

Somatropin - Dong-A ST

Alternative Names: DA-3002; Growtropin; Growtropin II; Growtropin-AQ; hGH - Dong-A ST; Human growth hormone - Dong-A ST

Latest Information Update: 19 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dong-A Pharmaceutical
  • Developer Dong-A ST
  • Class Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Short stature

Most Recent Events

  • 01 Feb 2016 Dong-A Pharmaceutical initiates a phase III trial for Short stature (In children, In adolescents; associated with small for gestational age at birth) in South Korea (Parenteral, Injection) (NCT02770157)
  • 16 Jul 2013 Biomarkers information updated
  • 28 Feb 2013 Dong-A Pharmaceutical initiates enrolment in a phase III trial for Short stature in children (associated with Turner's syndrome) in South Korea (NCT01813630)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top